Untreated Adult Acute Myeloid Leukemia Completed Phase 2 Trials for Filgrastim (DB00099)

IndicationStatusPhase
DBCOND0028532 (Untreated Adult Acute Myeloid Leukemia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00416598Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid LeukemiaTreatment
NCT01101880Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative NeoplasmTreatment